Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DOT1L | Q8TEK3 | 3/20 | 0.34 |
| ▸ | PRMT5 | O14744 | 2/20 | 0.32 |
| ▸ | WDR77 | Q9BQA1 | 2/20 | 0.32 |
| ▸ | METTL3 | Q86U44 | 1/20 | 0.32 |
| ▸ | DGAT1 | O75907 | 1/20 | 0.31 |
| ▸ | POLRMT | O00411 | 1/20 | 0.31 |
| ▸ | HTR4 | Q13639 | 1/20 | 0.30 |
| ▸ | TLR7 | Q9NYK1 | 2/20 | 0.30 |
| ▸ | AXL | P30530 | 1/20 | 0.30 |
| ▸ | MERTK | Q12866 | 1/20 | 0.30 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24791261 | 0.90 | MIF (0.34) | DOT1LPOLRMT | |
| SCHEMBL24606280 | 0.86 | DOT1L (0.35) | DOT1LPOLRMT | |
| SCHEMBL27121214 | 0.85 | DOT1L (0.34) | DOT1LDGAT1 | |
| SCHEMBL24606310 | 0.84 | DOT1L (0.36) | DOT1LPOLRMT | |
| SCHEMBL24606256 | 0.84 | DOT1L (0.34) | DOT1LPOLRMT | |
| SCHEMBL26027103 | 0.82 | DOT1L (0.36) | DOT1LPOLRMT | |
| SCHEMBL24606262 | 0.82 | DOT1L (0.36) | DOT1LPOLRMT | |
| SCHEMBL26237796 | 0.82 | CSNK2A2 (0.35) | DOT1LPOLRMTMAP4K4 | |
| SCHEMBL24606327 | 0.81 | DOT1L (0.34) | DOT1LPOLRMT | |
| SCHEMBL24606316 | 0.81 | DOT1L (0.34) | DOT1LPOLRMT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4328227-A1 | NUCLEOSIDE COMPOUND AND APPLICATION THEREOF IN THE TREATMENT OF FELINE INFECTIOUS PERITONITIS | Vigonvita Life Sciences Co., Ltd. (CN) | 2024-02-28 | — | — | EP | disclosed |